Anurag M, Jaehnig EJ, Krug K, et al. Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022;12(11):2586-2605. doi:10.1158/2159-8290.CD-22-0200
Publications
Funk L, Su KC, Ly J, et al. The phenotypic landscape of essential human genes. Cell. 2022. doi:10.1016/j.cell.2022.10.017
Paolicelli RC, Sierra A, Stevens B, et al. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110(21):3458-3483. doi:10.1016/j.neuron.2022.10.020
Sheriff A, Guri I, Zebrowska P, et al. ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation. Scientific reports. 2022;12(1):19643. doi:10.1038/s41598-022-24184-8
Girma E, Ametaj A, Alemayehu M, et al. Measuring Traumatic Experiences in a Sample of Ethiopian Adults: Psychometric Properties of the Life Events Checklist-5. European journal of trauma & dissociation = Revue europeenne du trauma et de la dissociation. 2022;6(4). doi:10.1016/j.ejtd.2022.100298
Chen ZZ, Pacheco JA, Gao Y, et al. Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans. Diabetes. 2022;71(11):2426-2437. doi:10.2337/db22-0033
Heianza Y, Wang X, Rood J, et al. Changes in circulating bile acid subtypes in response to weight-loss diets are associated with improvements in glycemic status and insulin resistance: The POUNDS Lost trial. Metabolism: clinical and experimental. 2022;136:155312. doi:10.1016/j.metabol.2022.155312
Pan XF, Chen ZZ, Wang TJ, et al. Plasma metabolomic signatures of obesity and risk of type 2 diabetes. Obesity (Silver Spring, Md.). 2022;30(11):2294-2306. doi:10.1002/oby.23549
Peng V, Cao S, Trsan T, et al. Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription. Proceedings of the National Academy of Sciences of the United States of America. 2022;119(45):e2214900119. doi:10.1073/pnas.2214900119
McClain KM, Sampson JN, Petrick JL, et al. Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Metabolites. 2022;12(12). doi:10.3390/metabo12121189